228
Participants
Start Date
August 31, 2014
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
Probiotic Bifidobacterium 1x1010 cfu
Participants who pass the initial screening will enter a 2-week placebo-only run-in period. Participants who successfully complete the run-in period will be randomized to daily supplementation with B. lactis HN019 (1 x 1010 cfu), B. lactis HN019 (1 x 109 cfu), or placebo for 4 weeks.
Probiotic Bifidobacterium 1x109 cfu
Participants who pass the initial screening will enter a 2-week placebo-only run-in period. Participants who successfully complete the run-in period will be randomized to daily supplementation with B. lactis HN019 (1 x 1010 cfu), B. lactis HN019 (1 x 109 cfu), or placebo for 4 weeks. One capsule of study product, mixed with provided yogurt, will be consumed once a day.
Placebo powder in capsules
Participants will consume placebo capsules only during the 2-week run-in period. After randomization, participants will be administered their assigned study product and will continue on the product for 4 weeks.
EUROFINS OPTIMED Clinical Research, Gières
Eurofins Optimed
INDUSTRY
Danisco Sweeteners Oy
INDUSTRY